Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
451
Harmony Gold Mining
HMY
$10.6B
| $46.7M | 0.04% |
11,205,720
-2,892,047
| -21% | -$9.52M |
2013 Q2
28 quarters
|
|
|
CWEN.A
452
DELISTED
Clearway Energy Class A
CWEN.A
| $46.6M | 0.04% |
2,221,630
+32,364
| +1% | +$632K |
2017 Q4
10 quarters
|
|
|
SGEN
453
DELISTED
Seagen Inc. Common Stock
SGEN
| $46.6M | 0.04% |
274,113
+254,813
| +1,320% | +$38M |
2019 Q3
3 quarters
|
|
454
DHT Holdings
DHT
$4B
| $46.4M | 0.04% |
9,047,619
-1,107,750
| -11% | -$7.06M |
2017 Q1
13 quarters
|
|
|
GOOD
455
Gladstone Commercial Corp
GOOD
$614M
| $46.4M | 0.04% |
2,474,015
-106,085
| -4% | -$1.74M |
2014 Q1
25 quarters
|
|
456
Nutrien
NTR
$33.6B
| $46.3M | 0.04% |
1,441,785
+656,400
| +84% | +$22.8M |
2019 Q3
3 quarters
|
|
457
Nice
NICE
$6.95B
| $46.1M | 0.04% |
243,563
+105,119
| +76% | +$18.4M |
2018 Q1
9 quarters
|
|
458
Omnicom Group
OMC
$21B
| $45.7M | 0.04% |
837,200
+633,919
| +312% | +$34.5M |
2019 Q4
2 quarters
|
|
459
CDW
CDW
$17.7B
| $45.4M | 0.04% |
390,598
+162,400
| +71% | +$17.6M |
2018 Q3
7 quarters
|
|
460
Fidelity National Financial
FNF
$10.5B
| $45.2M | 0.04% |
1,532,345
+423,377
| +38% | +$11.6M |
2019 Q4
2 quarters
|
|
461
OraSure Technologies
OSUR
$268M
| $45.2M | 0.04% |
3,884,150
+81,340
| +2% | +$1.06M |
2013 Q2
28 quarters
|
|
462
Paychex
PAYX
$37.5B
| $45.1M | 0.04% |
595,601
+386,500
| +185% | +$26.8M |
2020 Q1
1 quarter
|
|
463
SLB Ltd
SLB
$72.7B
| $45M | 0.04% |
2,447,204
-1,381,900
| -36% | -$24.2M |
2020 Q1
1 quarter
|
|
|
NSA
464
DELISTED
National Storage Affiliates Trust
NSA
| $45M | 0.04% |
1,569,602
-277,700
| -15% | -$7.96M |
2015 Q3
19 quarters
|
|
465
UnitedHealth
UNH
$339B
| $45M | 0.04% |
152,426
+99,100
| +186% | +$28.4M |
2020 Q1
1 quarter
|
|
|
PTR
466
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $44.8M | 0.04% |
1,355,147
+86,100
| +7% | +$3.04M |
2015 Q1
21 quarters
|
|
467
CVR Energy
CVI
$6.04B
| $44.8M | 0.04% |
2,225,384
-539,200
| -20% | -$10.9M |
2017 Q2
12 quarters
|
|
|
PGTI
468
DELISTED
PGT, Inc.
PGTI
| $44.7M | 0.04% |
2,850,229
-298,200
| -9% | -$3.59M |
2013 Q2
28 quarters
|
|
|
IMGN
469
DELISTED
Immunogen Inc
IMGN
| $44.5M | 0.04% |
9,665,139
-1,350,990
| -12% | -$5.75M |
2016 Q2
16 quarters
|
|
470
Western Union
WU
$1.96B
| $44.3M | 0.04% |
2,051,300
-73,376
| -3% | -$1.49M |
2016 Q2
16 quarters
|
|
471
National Healthcare
NHC
$3.53B
| $44.3M | 0.04% |
699,000
+33,200
| +5% | +$2.23M |
2013 Q2
28 quarters
|
|
472
Prologis
PLD
$122B
| $44M | 0.04% |
+471,914
| New | +$42.1M |
2020 Q2
0 quarters
|
|
473
Patterson-UTI
PTEN
$4.37B
| $44M | 0.04% |
12,683,157
+132,998
| +1% | +$459K |
2018 Q4
6 quarters
|
|
474
Eaton
ETN
$165B
| $44M | 0.04% |
+502,711
| New | +$41.4M |
2020 Q2
0 quarters
|
|
475
Planet Fitness
PLNT
$3.55B
| $43.9M | 0.04% |
+725,000
| New | +$43.5M |
2020 Q2
0 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.